About Race Oncology

About company

Race Oncology is a specialty pharmaceutical company whose business model is to pursue later stage drug assets, principally in the cancer field.Race Oncology has now rediscovered Bisantrene. In the United States, Race owns two granted patents on Bisantrene and has secured Orphan Drug designation and Rare Paediatric Disease designation. Our goal is to complete clinical development and gain approval by the US FDA.